FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: The Era of TIL Therapy Is Here!

Find latest Skin videos · 200+ videos

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: The Era of TIL Therapy Is Here!

By Stanford Medicine FEATURING Allison Betof Warner

1,008 views

March 11, 2024

Comments 1

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Oncology Data Advisor

M. Hadfield

350 views

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

2.0K views

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

S. Patel

809 views

ESMO 2024 Summary: Metastatic Melanoma Highlights

2024 ESMO Annual Meeting Insights Hub

C. Blank

213 views

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

Tarek Haykal

736 views

Optimal Treatment for BRAF-Mutated Metastatic Melanoma

Jeff Yorio

582 views

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

269 views

Advances in the Treatment of Melanoma

Masterclasses in Dermatology

D. Fisher

816 views

New Frontiers in Oncology: Advanced Diagnostics and Therapeutics

Springer Healthcare IME

S. Peters

179 views

ESMO 2024 Summary: Key Metastatic and Neoadjuvant Melanoma Trials

2024 ESMO Annual Meeting Insights Hub

D. Johnson

198 views

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and R…

2024 ASCO® Annual Meeting Insights Hub

D. Johnson

518 views

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Outcome…

2024 ASCO® Annual Meeting Insights Hub

H. Tawbi

433 views

ASCO® 2024 Summary: "Insights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

O. Hamid

470 views

Biomarkers for Immunotherapy in Melanoma: Where Are We Now?

Vanderbilt University Medical Center (VUMC)

D. Johnson

109 views

New

Year in Review 2024 - Melanoma

Oncology 2024 Year in Review

A. van Akkooi

113 views

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

423 views

Systemic Therapies for Melanoma and Immune Related Adverse Effects (…

Melanoma Research Foundation

S. Chandra

41 views

2024 SMR Congress Insights: Key Takeaways of Important Trials in Mel…

Roswell Park Comprehensive Cancer Center

I. Puzanov

127 views

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuva…

2024 ASCO® Annual Meeting Insights Hub

Z. Eroglu

327 views

The Impact of Microbiome on Immune Checkpoint Blockade Response in M…

Melanoma Research Foundation

Y. Seo

80 views

Login

Login

Join VuMedi

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: The Era of TIL Therapy Is Here!

Related Videos

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

ESMO 2024 Summary: Metastatic Melanoma Highlights

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

Optimal Treatment for BRAF-Mutated Metastatic Melanoma

ESMO 2024 Summary: Developmental Therapeutics Highlights

Advances in the Treatment of Melanoma

New Frontiers in Oncology: Advanced Diagnostics and Therapeutics

ESMO 2024 Summary: Key Metastatic and Neoadjuvant Melanoma Trials

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and R…

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Outcome…

ASCO® 2024 Summary: "Insights in Melanoma"

Biomarkers for Immunotherapy in Melanoma: Where Are We Now?

Year in Review 2024 - Melanoma

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

Systemic Therapies for Melanoma and Immune Related Adverse Effects (…

2024 SMR Congress Insights: Key Takeaways of Important Trials in Mel…

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuva…

The Impact of Microbiome on Immune Checkpoint Blockade Response in M…